Active, not recruitingNot applicableNCT02202590

Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus

Studying Primary eosinophilic gastrointestinal disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Guillermo Tearney, MD., PhD
Massachusetts General Hospital
Intervention
SECM Capsule(device)
Enrollment
96 enrolled
Eligibility
14 years · All sexes
Timeline
20132028

Study locations (1)

Collaborators

National Institutes of Health (NIH) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02202590 on ClinicalTrials.gov

Other trials for Primary eosinophilic gastrointestinal disease

Additional recruiting or active studies for the same condition.

See all trials for Primary eosinophilic gastrointestinal disease

← Back to all trials